
www.rsisinternational.org
INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XV, Issue V, May 2026
connections is used to extract features from brain image data and to classify normal and Alzheimer’s disease
image data. In this proposed framework for image classification, an accuracy of 95% is achieved in classification
with low loss using ADNI image data. In the paper published by Yao et al. [9], a brief idea about the use of Ai
in the diagnosis of Alzheimer’s disease by analyzing the MRI image data was provided. The various models of
Ml such as Attention Networks, Auto-Encoders, CNN, GANs, Deep Belief Networks, etc. have been discussed
for the identification of the structural changes that take place in the brain due to Hippocampal Atrophy and
Cortical De generation. The various advanced techniques such as Transfer Learning, Contrastive Learning, Meta
Learning, Federated Learning, Multimodal Data, etc. have been discussed for the early diagnosis of Alzheimer’s
disease. A model for the classification of Alzheimer’s disease using MRI brain images has been proposed by
Sharma et al. [10] using CNN-MobileNetV2. The authors have utilized differ ent preprocessing methods such
as median filtering, FFT, and DWT for enhancing the quality of the image. Feature extraction methods such as
HOG, GLCM, and PSO-SURF have also been utilized.
The extracted features have been employed for the classification of images into Normal Control, Mild Cognitive
Impairment, and Alzheimer’s Disease. The proposed model has achieved 97% accuracy on the Kaggle
MRIdataset compared to other models such as VGGNet, CNN and MobileNetV2. Lampe et al. [11] has
developed a ML model using volumet ric MRI imaging to predict and distinguish multiple dementia syndromes.
The models have been trained using T1-weighted MRI scans of 426 patients and 51 healthy participants. The
binary models have demonstrated 71% to 95% accuracy in the models, and the multi-syndrome classifier
demonstrated an accuracy of 47.4% in distinguishing seven different dementia syndromes. The models have
demonstrated higher accuracy in models with distinct brain atrophy patterns like svPPA, bvFTD, and PSP.
Sharma et al. [12] proposed a model using deep learning with CNN for detecting Alzheimer’s disease by
analyzing the MRI scans of brain images. The proposed model was trained on two different datasets of MRI
scans, one containing 6400 images and the other containing 6330 images. The images were categorized into
various stages, such as Non-Demented, Very Mild Demented, Mild Demented, and Moderate De mented.
The VGG16 model was employed to extract features from MRI scans, and a neural network was employed to
classify images. The proposed model attained an accuracy of 90.4%, precision of 0.905, recall of 0.904, F1 score
of 0.904, and area under the curve of 0.969 on the first dataset. The proposed model validated that deep learning
using VGG16 is efficient for diagnosing early-stage Alzheimer’s disease. Lee et al. [13] proposed the brain
imaging abnormalities in mixed Alzheimer’s disease and subcortical vascular dementia using advanced MRI
techniques such as T2-FLAIR MRI, DTI, QSM, and R2 relaxation.
They analyzed the data from 17 participants (5 AD, 5 SVaD, 7 mixed dementia) and observed that the patients
suffering from mixed dementia have higher white matter signal abnormalities, especially in the frontal lobes,
and lower R2 values compared to the patients suffering from Ad and subcortical Vd.
It has been observed that the mixed dementia shows imaging characteristics of both Alzheimer’s and vascular
brain damage, which indicates that the MRI biomarkers can help in the differential diagnosis of the different
types of dementia. Alizadeh et al. [14] in the study have proposed a deep learning method based on the analysis
of the rs-fMRI data for the classification of Alzheimer’s disease, Mild Cognitive Impairment, and normal
controls. In the proposed method, the BOLD signal in 39 brain regions, according to the MSDL atlas, has been
used. A 1D CNN has been proposed in the study to classify Ad and normal controls.
The dataset, which consists of 15 Alzheimer’s disease patients, 17 Mild Cognitive Impairment patients, and 10
normal controls, has been used in the proposed method. The signal augmentation has been used in the study to
increase the size of the dataset. The experimental results show that the overall accuracy of the proposed method
is 68.5%, the precision is 0.681 and the F1 score is 0.663. In the paper presented by Basheer et al. [15], a novel
model named MCapNet, which is a modified deep neural network using capsule network architecture, has been
introduced for predicting dementia using the OASIS MRI dataset. The dataset considered has 373 samples with
15 clinical and imaging features. The dataset has been classified into demented and non-demented. The EDA
analysis has shown that age and gender play a significant role in predicting dementia. The model introduced,
i.e., MCapNet, has shown 92.39% accuracy compared to other Ml classifiers such as Decision Trees, Random
Forest, SVM, Gradient Boosting, etc.